Yep. Save cash?... to what end? As has been repeated, sell now or try to make it happen. I'll be interested to see with whom, if anyone, they did the PLA studies. And there's still the case of Pharmafilter installing another unit in 2015 in Rotterdam. When the deuce are they gonna start a pilot plant? Maybe my brain needs a PET scan.
my guess is the same as yours. With the cc coming up I guess there is no pressure to explain details now unless they included sizable cash to mblx. I doubt the cash idea is likely and I could see how both would rather have mblx take a share of the business or guaranteed minimum purchases of pha.
Looking what mblx must accomplish, I don't know if the the cash savings here is nearly as important as freeing up more focus business model driven by new CEO. They seem more out of final product game (with respect to PHA business) and more inline with PHA as an additive (even the German company would be using it as a part of formulations).
The more tightly aligned and streamlined MBLX specialty chemical company makes sense. Hopefully Shaulson has the company aligning around what he sees as core competencies and best opportunities.
Sentiment: Strong Buy
No clarification on "acquire" but I'm gonna guess that the " Security of supply..." and "...mutually assured through contract negotiations." means licensing of some kind. Interesting find.
Here is the translated text from Akro's site today. Happy MBLX's employees were looked after and that MBLX will be more focused on where margins should be bigger. In any event, here is Akro's statement:
AKRO-PLASTIC to acquire parts of the Metabolix bio-plastic portfolio
AKRO-PLASTIC GmbH, manufacturer of engineering plastics compounds with headquarters in Niederzissen, in the Rhineland-Palatinate region of Germany, will acquire a product range of biodegradable, compostable compounds from Metabolix, Inc. (Cambridge, Massachusetts / USA), a manufacturer of polyhydroxyalkanoates (PHA).
The product range, developed and successfully launched by Metabolix under the brand name "Mvera", will henceforth be marketed and further developed by AKRO-PLASTIC GmbH through its BIO-FED branch located on BioCampus Cologne, Nattermannallee 1, Cologne, Germany. Security of supply for customers and the transfer of all required technologies and IP to AKRO-PLASTIC have been mutually assured through contract negotiations. Moreover, the two companies intend to continue working together in future in the area of PHA products and blends. All European employees of Metabolix will continue their work with AKRO-PLASTIC at the BIO-FED branch
Sentiment: Strong Buy
Metabolix to Present Data Showing That Biobased PHA Copolymers Deliver Key Performance Improvements in PVC and PLA Compounds
Company to Present Data on Mirel® Performance Additives at Vinyltec 2014 and ADDCOM Conferences
Actually that made a nice profit on shorting. Though there were other reasons for shorting at that point and nothing to do with MM's
Normey I never suspected for a moment you are calling me anything inappropriate.
Essentially with CFDs you do not actually own the underlying asset that you are trading because it is a derived instrument. The prices are derived from the underlying asset and these prices move in conjunction with that underlying asset.
You can get up to 20 times your collateral so there is a high degree of risk to your capital. Losses can quickly and substantially exceed your initial investment. You may need to make further margin payments. You need to fully understand the risks and seek independent advice if necessary.
With underlying assets such as stocks I can get a margin of 50% which I use for my normal portfolio, such as the SZYM I recently stated I went long and will continue to hold. That is a totally different asset class to a CFD.
But this can't work without a willing bettor on the other side. Is there some other market for these transactions where the transactions are reported? To use Vegas terminology, what house takes this sort of bet? In sports bets Vegas needs to roughly cover winners by the losers and profit off the spread. Sure there are times where Vegas will take some additional risk but they don't go all-in on the risk ever. In any event, if the underlying security either transfers or doesn't based on the spread bet it seems there should be some transaction at the Nasdaq level then (at least in the event of the spread bet transfer going through). And even if NASDAQ doesn't have anything to do with these CFD bets, there must be some known market trading the CFDs. I'm not calling you a liar but need to understand where such a large transaction for such a lightly traded stock can take place.
Sentiment: Strong Buy
Hi Normey. I might suggest a quick CFD search for better explanation but a brief one. There are no short or borrowing rules with CFD's as there is no underlying asset to be held. It is a spread bet and not an asset owning transaction. So a derivative. It is no different than placing a bet on a horse that it will win or place in a race. A CFD is a bet that the stock will go up or down with a spread betting house/bank.
I'm a bit confused here. Sorry I'm not that experienced on CFD's but at some point doesn't there need to be a matching transaction on the other side that would cover the 50,000 shares? I mean on some exchange it needs to show up right? That's a huge chunk of mblx stock by recent trading standards and it would have some wake that it causes right?
Sentiment: Strong Buy
I always use CFD derivitives for trading in highly volatile but low volume stocks. In the small amount of times I have used the underlying stock I tended to trade no more than 25% of the volume of the average. In the case of my recent SZYM it is a portfolio item so I bought the underlying stock.
The split is because they ran out of money, massively diluted existing stockholders and the stock price tumbled so low that they need to do a reverse split so that they can stay on NASDAQ.
To show I have no bias to being short I have just gone long on SZYM. I suspect it hit bottom just below $6 today I expect to ride this out to $8. I know it is not the right board.
Came back and checked my email to see that I had an exit trigger at bid of $0.75. A nice $10k to add to the kitty. I still see this dropping to $0.65 before the dilution but I am happy with my unexpected early exit. Good luck to all longs. Shorts is too tight to get in if the target is only another $0.10.
The split is so the stock will look more like something bigger money investitures well want. For bigger buyers. There is big money coming in soon.